(Q41035105)

25 September 2017

1 reference

title

Chronic psychiatric patients' use of caffeine: pharmacological effects and mechanisms (English)

1 reference

25 September 2017

Kruger A

1

1 reference

PubMed ID

8711047

25 September 2017

language of work or name

English

1 reference

inferred from

Psychological Reports

publication date

1 June 1996

1 reference

25 September 2017

Psychological Reports

1 reference

25 September 2017

78

1 reference

25 September 2017

3 Pt 1

1 reference

25 September 2017

915-923

1 reference

Caffeine abstention in the management of anxiety disorders

25 September 2017

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Possible psychiatric significance of excessive coffee consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

The changing drug scene: 1970-1972.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Response to "Effects of caffeine on behavior of schizophrenic inpatients".

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Effects of caffeine on behavior of schizophrenic inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Modification by caffeine of the sensitization to methamphetamine and cocaine in terms of ambulation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Caffeine withdrawal increases lithium blood levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Adenosine modulation of synaptosomal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Methylxanthines elevate reinforcement threshold for electrical brain stimulation: role of adenosine receptors and phosphodiesterase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Heterocyclic amphetamine derivatives and caffeine on sleep in man

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Patterns of caffeine use and prescribed medications in psychiatric inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Methylxanthines: toxicity to humans. 2. Caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Caffeine-induced delirium during prolonged competitive stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Caffeine dependence syndrome. Evidence from case histories and experimental evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

The analgesic effects of caffeine in headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Coffee consumption among psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2466%2FPR0.1996.78.3.915

10.2466/PR0.1996.78.3.915

21 January 2018

Identifiers

DOI

0 references

PubMed ID

8711047

1 reference

PubMed ID

8711047